All News Qiagen N.V. Deutsche Boerse AG

Equities

Market Closed - Deutsche Boerse AG Other stock markets 18:59:07 08/07/2024 BST			After market 21:00:00
37.12 ^EUR	-1.69%		37.26	+0.38%

06-27	Wolfe Research Upgrades Qiagen to Outperform From Peer Perform, Price Target is $50	MT
06-21	Qiagen Seeks M&A	CI

QIAGEN to enhance the identification of human remains of Indigenous people and African Americans	09:05pm	AQ
QIAGEN N.V. to release results for Q2 2024 and hold webcast	07-02	AQ
QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in children	06-27	AQ
Qiagen N : AGM 2024 Voting Results	06-27	PU
Wolfe Research Upgrades Qiagen to Outperform From Peer Perform, Price Target is $50	06-27	MT
Qiagen Seeks M&A	06-21	CI
Transcript : Qiagen N.V. - Shareholder/Analyst Call	06-21
Qiagen N : Stifel – European Healthcare Summit Capital Markets Day Presentation	06-20	PU
Qiagen N : Stifel – European Healthcare Summit Infographic	06-20	PU
Sartorius on the downswing again - low since 2020 is approaching	06-19	DP
Invest Securities Raises Qiagen PT, Maintains Neutral Rating	06-19	MT
UBS Raises Qiagen Price Target to $46 From $44, Maintains Neutral Rating	06-18	MT
JPMorgan Raises Price Target on Qiagen to $54 From $52, Maintains Overweight Rating	06-18	MT
QIAGEN NV : Gets a Neutral rating from UBS	06-18	ZD
QIAGEN NV : Deutsche Bank reaffirms its Buy rating	06-18	ZD
QIAGEN NV : Berenberg remains its Buy rating	06-18	ZD
Frankfurt shares close: Dax recovers	06-17	DP
Transcript : Qiagen N.V. - Analyst/Investor Day	06-17
Dpa-AFX Overview: COMPANIES from 17.06.2024 - 15:15	06-17	DP
Qiagen Targets 7% Annual Sales Growth Through 2028	06-17	MT

No results for this search

QIAGEN : A decent start to 2024; guidance unchanged

April 30, 2024 at 02:32 pm